iSpecimen (ISPC) Competitors

Data Knights Acquisition (NASDAQ:DKDCA) and iSpecimen (NASDAQ:ISPC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

Is DKDCA or ISPC more profitable?

Data Knights Acquisition has a net margin of 0.00% compared to Data Knights Acquisition's net margin of -111.81%. iSpecimen's return on equity of 0.00% beat Data Knights Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Data Knights Acquisition	N/A	N/A	-5.55%
iSpecimen	-111.81%	-80.37%	-61.99%

Do analysts recommend DKDCA or ISPC?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Data Knights Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
iSpecimen	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media refer more to DKDCA or ISPC?

In the previous week, iSpecimen had 1 more articles in the media than Data Knights Acquisition. MarketBeat recorded 1 mentions for iSpecimen and 0 mentions for Data Knights Acquisition. iSpecimen's average media sentiment score of 0.00 equaled Data Knights Acquisition'saverage media sentiment score.

Company	Overall Sentiment
Data Knights Acquisition	Neutral
iSpecimen	Neutral

Do insiders and institutionals hold more shares of DKDCA or ISPC?

35.3% of Data Knights Acquisition shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 45.7% of Data Knights Acquisition shares are owned by company insiders. Comparatively, 32.7% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in DKDCA or ISPC?

iSpecimen received 3 more outperform votes than Data Knights Acquisition when rated by MarketBeat users.

Company	Underperform	Outperform
Data Knights Acquisition	N/A	N/A
iSpecimen	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%

Which has more volatility and risk, DKDCA or ISPC?

Data Knights Acquisition has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, iSpecimen has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500.

Which has higher valuation and earnings, DKDCA or ISPC?

Data Knights Acquisition has higher earnings, but lower revenue than iSpecimen. Data Knights Acquisition is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Data Knights Acquisition	N/A	N/A	$340K	-$0.19	-3.42
iSpecimen	$9.93M	0.40	-$11.10M	-$1.23	-0.34

Summary

Data Knights Acquisition beats iSpecimen on 7 of the 12 factors compared between the two stocks.